Discontinuation of Lens Wear in New Ortho-k Children (DOEE2)

Myopia Clinical Trial

— DOEE2  

Official title:

Discontinuation of Orthokeratology on Eyeball Elongation (DOEE) Study. (2) Discontinuation of Lens Wear in New Ortho-k Children

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01236755
• Other study ID #: H-ZG50-2
• Status: Completed
• Phase: N/A
• Start date: October 2010
• Est. completion date: December 2013

Study information

• Verified date: February 2020
• Source: The Hong Kong Polytechnic University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims at investigating the efficacy of myopic control using ortho-k in younger and older children.

Description:

Children wearing ortho-k have been shown to have slower rate of myopic progression than those wearing single-vision spectacles (Cho et al. 2005) or soft lenses (Walline et al. 2009). Younger myopic children (aged 6-10 years old) may have the faster increase in myopia than old myopic children (aged 11-15 years old), i.e. the rate of myopic progression may be different in different age groups and in children with different refractive status (Edwards 1999; Fan et al. 2004; Cheng et al. 2007). Although the refractive correction with ortho-k has been well documented, it is unknown whether the efficiency and reversibility of ortho-k for myopic reduction as well as myopic control are similar in children of different age and refractive groups.

In this 14-month study, the eyeball length in 45 younger (6-10 years old) and 45 older (11-15 years old) myopic children before and after ortho-k will be evaluated. Eyeball elongation will be determined for the first 7 months when single-vision glasses will be prescribed (Phase I) and the next 7 months when ortho-k will be prescribed (Phase I). Rate of myopic progression will be determined and compared between the two groups of children in the two phases.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 91
• Est. completion date: December 2013
• Est. primary completion date: July 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 6 Years to 15 Years

Eligibility

Inclusion Criteria:

• Age: between 6 to 15 years old

• Myopia: between 1.50D and 4.50D in at least one eye

• Spherical equivalent (SE): between -1.00D to -4.50D in both eyes

• Astigmatism: = 3.00D of axes 180 +/- 30 or = 1.00D of other axes; and the amount is less than refractive sphere

• Anisometropia: = 1.50D in both refractive sphere, refractive cylinder and SE

• Best corrected monocular visual acuity: equal to or better than 0.10 in logMAR scale in both eyes

• Willingness to wear contact lenses or spectacles on a daily basis

• Can obtain good ortho-k results with the study lenses

• Availability for follow-up for at least 14 months

Exclusion Criteria:

• Strabismus at distance or near

• Contraindication for contact lens wear and ortho-k (e.g. limbus to limbus corneal cylinder and dislocated corneal apex

• Systemic or ocular conditions which may affect contact lens wear (e.g. allergy and medication)

• Systemic or ocular conditions which may affect refractive development (e.g. Down syndrome, ptosis)

• Prior experience with the use of rigid lenses (including ortho-k)

• Prior experience with myopia control treatment (e.g. refractive therapy or progressive spectacles)

• Non-compliance to the follow up schedule

• Non-compliance to the use of the prescribed optical correction

• Poor ocular response to ortho-k lens wear

• Significant residual refractive error after ortho-k treatment resulting in poor unaided vision (worse than 0.18 in logMAR scale)

Related Conditions & MeSH terms

• Myopia

Intervention

Device:
• single-vision glasses
Daily wear of glasses to correct vision in the first seven months of the study
• ortho-k lenses
Nightly wear of lenses to correct vision in day time in the second seven months of the study

Locations

Country	Name	City	State
China	School of Optometry, The Hong Kong Polytechnic University	Hong Kong	Hong Kong

Sponsors (2)

Lead Sponsor	Collaborator
The Hong Kong Polytechnic University	Menicon Co., Ltd.

Country where clinical trial is conducted

China, 

References & Publications (6)

Cheng D, Schmid KL, Woo GC. Myopia prevalence in Chinese-Canadian children in an optometric practice. Optom Vis Sci. 2007 Jan;84(1):21-32. — View Citation

Cheung SW, Boost MV, Cho P. Pre-treatment observation of axial elongation for evidence-based selection of children in Hong Kong for myopia control. Cont Lens Anterior Eye. 2019 Aug;42(4):392-398. doi: 10.1016/j.clae.2018.10.006. Epub 2018 Oct 24. — View Citation

Cho P, Cheung SW, Edwards M. The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res. 2005 Jan;30(1):71-80. — View Citation

Edwards MH. The development of myopia in Hong Kong children between the ages of 7 and 12 years: a five-year longitudinal study. Ophthalmic Physiol Opt. 1999 Jul;19(4):286-94. — View Citation

Fan DS, Lam DS, Lam RF, Lau JT, Chong KS, Cheung EY, Lai RY, Chew SJ. Prevalence, incidence, and progression of myopia of school children in Hong Kong. Invest Ophthalmol Vis Sci. 2004 Apr;45(4):1071-5. — View Citation

Walline JJ, Jones LA, Sinnott LT. Corneal reshaping and myopia progression. Br J Ophthalmol. 2009 Sep;93(9):1181-5. doi: 10.1136/bjo.2008.151365. Epub 2009 May 4. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Axial Elongation in the Two Study Phases	Axial elongation in children during the two study phases. Phase I: 7 months wearing single-vision spectacles. Phase II: 7 months wearing orthokeratology	14 months
Secondary	Number of Participants With Serious Adverse Effects	Number of subjects with serious adverse effects of the cornea, the palpebral, bulbar and tarsal conjunctiva	14 months